IMPACT - Integrative Medicine PrimAry Care Trial
Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis
Laminar Airflow in Severe Asthma for Exacerbation Reduction - 48 Month Follow-up.
|4||Enrolling by invitation||
Mission is Remission®: How Can a Disease Self-management Website Change Care?
† Study has passed its completion date and status has not been verified in more than two years.